Gut microbiota dysbiosis and Long COVID susceptibility in chronic kidney disease
- 1Department of Nephrology Beijing Chao‐Yang Hospital Capital Medical University Beijing China
- 2Department of Respiratory and Critical Care Medicine Beijing Institute of Respiratory Medicine Beijing Chao‐Yang Hospital Capital Medical University Beijing China
Abstract
Patients with chronic kidney disease (CKD) may be more susceptible to long coronavirus disease (Long COVID), yet the underlying mechanisms remain unclear. In this case‒control study, 224 patients receiving maintenance hemodialysis who experienced severe acute respiratory syndrome coronavirus 2 infection were enrolled, among whom 35.3% developed Long COVID. Long COVID predominantly manifested as neurological symptoms, including fatigue (43.0%), sleep disturbances (29.1%), and memory impairment (24.1%), and was accompanied by elevated inflammatory markers such as interleukin‐6, high‐sensitivity C‐reactive protein, C‐reactive protein, and parathyroid hormone compared with CKD patients without Long COVID. Metagenomic sequencing and untargeted metabolomics were performed on fecal and serum samples from patients with Long COVID (LC‐CKD), matched CKD controls without Long COVID (NLC‐CKD), and healthy controls (NLC‐Control). LC‐CKD patients exhibited significant gut microbiota dysbiosis, characterized by an increased Firmicutes/Bacteroidetes ratio, depletion of beneficial genera including Phocaeicola and Prevotella, and enrichment of proinflammatory taxa such as Blautia and urease‐producing Lachnospiraceae. Metabolomic analysis revealed systemic metabolic alterations in LC‐CKD patients, including elevated uremic toxins, reduced prostaglandins, and disrupted tryptophan and tyrosine metabolism associated with Phocaeicola abundance. Distinct microbial virulence profiles were also observed, with upregulation of urease‐related genes (ureG and ureB) and stress‒response factors (groEL and sugC). Fecal microbiota transplantation from LC‐CKD patients into 5/6 nephrectomized mice induced anxiety‐like behaviors and increased neuroinflammatory markers, mirroring microbial alterations in donors. These findings indicate that gut microbiota dysbiosis is associated with increased susceptibility to These findings suggest an association between gut microbiota dysbiosis and increased susceptibility to Long COVID in CKD patients, potentially mediated through microbe–metabolite interactions, highlighting the need for further mechanistic studies to validate potential microbiota‐targeted interventions.
Related
- Gut Microbiota Dysbiosis in Advanced Chronic Kidney Disease and Kidney Transplantation: A Narrative Review of Pathophysiological Mechanisms, Implications for Nutritional Status, and Biotic Interventions
- Gut-kidney axis in chronic kidney disease: Dysbiosis, uremic metabolites and therapeutic opportunities (Review)
- Ureic clearance granule ameliorates chronic kidney disease by reshaping microbial dysbiosis via modulating bile acid metabolism
- From Dysbiosis to Disease: How Vaginal Microbiota Shape Group B Streptococcus Pathogenesis
- Gut microbiota in type 2 diabetes mellitus: mechanistic links between dysbiosis, insulin resistance, and chronic low-grade inflammation
BibTeX
@article{jin2026microbiota,
title = {{Gut microbiota dysbiosis and Long COVID susceptibility in chronic kidney disease}},
author = {Meiling Jin and Lijie Ma and Yuqing Yuan and Kaiyi Zhu and Zhaohui Tong and Qianmei Sun},
journal = {View},
year = {2026},
month = oct,
doi = {10.1002/viw.20260021},
url = {https://doi.org/10.1002/viw.20260021},
note = {CC BY},
}
RIS
TY - JOUR
TI - Gut microbiota dysbiosis and Long COVID susceptibility in chronic kidney disease
AU - Meiling Jin
AU - Lijie Ma
AU - Yuqing Yuan
AU - Kaiyi Zhu
AU - Zhaohui Tong
AU - Qianmei Sun
PY - 2026
DA - 2026/10/26
JO - View
DO - 10.1002/viw.20260021
UR - https://doi.org/10.1002/viw.20260021
AB - Patients with chronic kidney disease (CKD) may be more susceptible to long coronavirus disease (Long COVID), yet the underlying mechanisms remain unclear. In this case‒control study, 224 patients receiving maintenance hemodialysis who experienced severe acute respiratory syndrome coronavirus 2 infection were enrolled, among whom 35.3% developed Long COVID. Long COVID predominantly manifested as neurological symptoms, including fatigue (43.0%), sleep disturbances (29.1%), and memory impairment (24.1%), and was accompanied by elevated inflammatory markers such as interleukin‐6, high‐sensitivity C‐reactive protein, C‐reactive protein, and parathyroid hormone compared with CKD patients without Long COVID. Metagenomic sequencing and untargeted metabolomics were performed on fecal and serum samples from patients with Long COVID (LC‐CKD), matched CKD controls without Long COVID (NLC‐CKD), and healthy controls (NLC‐Control). LC‐CKD patients exhibited significant gut microbiota dysbiosis, characterized by an increased Firmicutes/Bacteroidetes ratio, depletion of beneficial genera including Phocaeicola and Prevotella, and enrichment of proinflammatory taxa such as Blautia and urease‐producing Lachnospiraceae. Metabolomic analysis revealed systemic metabolic alterations in LC‐CKD patients, including elevated uremic toxins, reduced prostaglandins, and disrupted tryptophan and tyrosine metabolism associated with Phocaeicola abundance. Distinct microbial virulence profiles were also observed, with upregulation of urease‐related genes (ureG and ureB) and stress‒response factors (groEL and sugC). Fecal microbiota transplantation from LC‐CKD patients into 5/6 nephrectomized mice induced anxiety‐like behaviors and increased neuroinflammatory markers, mirroring microbial alterations in donors. These findings indicate that gut microbiota dysbiosis is associated with increased susceptibility to These findings suggest an association between gut microbiota dysbiosis and increased susceptibility to Long COVID in CKD patients, potentially mediated through microbe–metabolite interactions, highlighting the need for further mechanistic studies to validate potential microbiota‐targeted interventions.
SN - 2688-268X
SN - 2688-3988
ER -